Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole

Clinical Pharmacology and Therapeutics
P J NeuvonenK T Kivistö

Abstract

Itraconazole increases the risk of skeletal muscle toxicity of some 3-hydroxy-3-methylglutaryl coenzyme A' (HMG-CoA) reductase inhibitors by increasing their serum concentrations. We studied possible interactions of itraconazole with simvastatin and pravastatin. Two randomized, double-blind, two-phase crossover studies were performed with use of an identical design, one with simvastatin (study I) and one with pravastatin (study II). In both studies, 10 healthy volunteers received either 200 mg itraconazole or placebo orally once a day for 4 days. On day 4, each subject ingested a single 40 mg dose of simvastatin (study I) or pravastatin (study II). Serum concentrations of simvastatin, simvastatin acid, pravastatin, HMG-CoA reductase inhibitors, itraconazole, and hydroxyitraconazole were determined. In study I, itraconazole increased the peak serum concentrations (Cmax) and the areas under the serum concentration-time curve [AUC(0-infinity)] of simvastatin and simvastatin acid at least tenfold (p < 0.001). The Cmax and AUC(0-infinity) of total simvastatin acid (naive simvastatin acid plus that derived by hydrolysis of the lactone) were increased 17-fold and 19-fold (p < 0.001), respectively, and the half-life (t1/2) was increase...Continue Reading

References

May 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S MuramatsuH Takahagi
Feb 1, 1992·Journal of Clinical Pharmacology·P J PentikainenJ D Rogers
Feb 1, 1990·British Journal of Clinical Pharmacology·S M SinghviD A Willard
Jan 7, 1988·The New England Journal of Medicine·D J NormanJ Hosenpud
Sep 7, 1995·The New England Journal of Medicine·R S Lees, A M Lees
Oct 1, 1994·Pharmacogenetics·J C KolarsP B Watkins
Jul 1, 1996·Clinical Pharmacology and Therapeutics·P J Neuvonen, K M Jalava
Sep 1, 1996·British Journal of Clinical Pharmacology·K T KivistöH K Kroemer
Sep 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M F SegaertJ Verbanck

❮ Previous
Next ❯

Citations

Nov 1, 2007·Nature Reviews. Drug Discovery·Russell A WilkeRonald M Krauss
Sep 19, 2002·British Journal of Clinical Pharmacology·Teddy KosoglouMelton B Affrime
Jan 22, 2003·British Journal of Clinical Pharmacology·Kelvin J CooperDennis W Schneck
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M P DubéUNKNOWN Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
Feb 11, 2012·QJM : Monthly Journal of the Association of Physicians·S BhattacharyyaA Maitra
Nov 23, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Chi-Chi PengNina Isoherranen
May 9, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Zhe-Yi HuS Casey Laizure
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Er-jia WangWilliam W Johnson
Aug 16, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinichiro NishioKyoichi Ohashi
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael P DubéUNKNOWN HIV Medical Association of the Infectious Disease Society of America
Mar 22, 2001·British Journal of Clinical Pharmacology·L ZivianiL E Iavarone
Jun 11, 2015·Expert Opinion on Drug Metabolism & Toxicology·Takeshi Hirota, Ichiro Ieiri
Oct 15, 2011·Expert Opinion on Drug Metabolism & Toxicology·Paul O Gubbins
Oct 13, 2005·Expert Opinion on Pharmacotherapy·Paul O Gubbins, Jarrett R Amsden
Jun 21, 2005·British Journal of Clinical Pharmacology·Aukje K Mantel-TeeuwisseAnthonius de Boer
Mar 27, 2007·Pharmacotherapy·Espen Molden, Kirsti Svendsen Andersson
Oct 27, 2006·Pharmacotherapy·Carol W HoltzmanSarah A Spinler
Aug 26, 1999·Drug Metabolism Reviews·M Strolin Benedetti, M Bani
Oct 13, 2007·Current Medical Research and Opinion·Surya P AyalasomayajulaGangadhar Sunkara
Jan 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·Hugh A BartonManthena V Varma
Feb 24, 2011·Expert Opinion on Drug Safety·Thura T Abd, Terry A Jacobson
Dec 2, 2004·Expert Opinion on Pharmacotherapy·Terje R Pedersen, Jonathan A Tobert
Aug 24, 2007·Expert Opinion on Pharmacotherapy·Jennifer G Robinson
Oct 12, 2007·Expert Opinion on Pharmacotherapy·Toshio HayashiAkihisa Iguchi
Oct 5, 2001·Expert Opinion on Pharmacotherapy·C R Worz, M Bottorff
Aug 24, 2006·Expert Opinion on Pharmacotherapy·Michael H Davidson, Jennifer G Robinson
Nov 4, 2000·Expert Opinion on Investigational Drugs·M J Tikkanen
Dec 20, 2011·Expert Opinion on Drug Metabolism & Toxicology·Gopal KrishnaEdward O'Mara
Apr 12, 2008·Journal of Pharmacological Sciences·Kumi SatohKazuo Ichihara
Jun 5, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Matti K ItkonenJanne T Backman
Aug 4, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yannick ParmentierBernard Walther
Jul 5, 2003·The Annals of Pharmacotherapy·Aasma ShaukatMaria R Baer
Dec 28, 2016·Biopharmaceutics & Drug Disposition·Shunsuke NashimotoMitsuru Sugawara
Jul 30, 1999·Journal of the American Academy of Dermatology·A K GuptaN H Shear
Feb 21, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yoshihisa ShitaraYuichi Sugiyama

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.